Sugitani Iwao, Kazusaka Hiroko, Ebina Aya, Shimbashi Wataru, Toda Kazuhisa, Takeuchi Kengo
Department of Endocrine Surgery, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.
Division of Head and Neck, Cancer Institute Hospital, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
World J Surg. 2023 Feb;47(2):382-391. doi: 10.1007/s00268-022-06705-8. Epub 2022 Aug 16.
Guidelines universally recommend total thyroidectomy for high-risk papillary thyroid carcinoma (PTC). However, in Japan, thyroid-conserving surgery had been widely applied for such patients until recently. We investigated long-term outcomes for this strategy.
A prospectively recorded database was retrospectively analyzed for 368 patients who had undergone curative surgery for high-risk PTC without distant metastasis between 1993 and 2013. High-risk PTC was defined for tumors showing tumor size > 4 cm, extrathyroidal extension, or large nodal metastasis ≥ 3 cm.
Median age was 59 years and 243 patients were female. Mean duration of follow-up was 12.7 years. Lobectomy was conducted for 207 patients (LT group) and total or near-total thyroidectomy for 161 patients (TT group). The frequency of massive extrathyroidal invasion and large nodal metastasis was lower in the LT group than in the TT group. After propensity score matching, no significant differences were seen between groups for overall survival, cause-specific survival or distant recurrence-free survival. In the overall cohort, multivariate analysis identified age ≥ 55 years, large nodal metastasis, tumor size > 4 cm and massive extrathyroidal invasion as significantly associated with cause-specific survival, whereas extent of thyroidectomy was not.
For patients with high-risk PTC without distant metastasis, curative surgery with lobectomy showed almost identical oncological outcomes compared to total thyroidectomy. The benefits of total thyroidectomy for high-risk PTC should be reevaluated in the future prospective studies.
指南普遍推荐对高危乳头状甲状腺癌(PTC)行全甲状腺切除术。然而,在日本,直到最近甲状腺保留手术仍广泛应用于这类患者。我们研究了该策略的长期疗效。
对1993年至2013年间接受了针对无远处转移的高危PTC的根治性手术的368例患者的前瞻性记录数据库进行回顾性分析。高危PTC定义为肿瘤大小>4 cm、甲状腺外侵犯或大的淋巴结转移≥3 cm。
中位年龄为59岁,243例患者为女性。平均随访时间为12.7年。207例患者行叶切除术(LT组),161例患者行全甲状腺或近全甲状腺切除术(TT组)。LT组中广泛甲状腺外侵犯和大的淋巴结转移的发生率低于TT组。倾向评分匹配后,两组间总生存、病因特异性生存或远处无复发生存无显著差异。在整个队列中,多因素分析确定年龄≥55岁、大的淋巴结转移、肿瘤大小>4 cm和广泛甲状腺外侵犯与病因特异性生存显著相关,而甲状腺切除范围并非如此。
对于无远处转移的高危PTC患者,与全甲状腺切除术相比,行叶切除术的根治性手术显示出几乎相同的肿瘤学结局。全甲状腺切除术对高危PTC的益处应在未来的前瞻性研究中重新评估。